Jim Cramer on Intuitive Surgical: “It’s Just Gotten Too Expensive Per Share”

Core Viewpoint - Intuitive Surgical, Inc. (NASDAQ:ISRG) is facing challenges due to high stock multiples despite good earnings, with hospital utilization being the most critical metric for the company [1] Group 1: Company Overview - Intuitive Surgical designs and manufactures robotic systems for minimally invasive surgical and diagnostic procedures [3] - The company maintains a de facto monopoly in soft tissue robotic surgery globally, becoming the standard of care in many surgical modalities [3] Group 2: Investment Insights - Polen Capital Management initiated a 2.25% position in Intuitive Surgical in Q4 2025, selling positions in Netflix and Workday [3] - The company has launched a next-generation platform expected to accelerate procedure and revenue growth for years [3] - Current results indicate business momentum and a reasonable valuation, considering the company's accelerating monopoly [3]